Atypical immunologic response in a patient with CRIM-negative Pompe disease

Documenti analoghi

• Letter to the Editors: Concerning “CRIM-Negative Pompe Disease Patients with Satisfactory Clinical Outcomes on Enzyme Replacement Therapy” by Al Khallaf et al
  di: Prater, Sean N., et al.
  Pubblicazione: (2013)
• Predicting Cross Reactive Immunological Material (CRIM) Status in Pompe Disease Using GAA Mutations: Lessons Learned from 10 Years of Clinical Laboratory Testing Experience
  di: Bali, Deeksha S., et al.
  Pubblicazione: (2012)
• Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease
  di: Messinger, Yoav H., et al.
  Pubblicazione: (2012)
• CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
  di: Berrier, Kathryn L., et al.
  Pubblicazione: (2015)
• High dose IVIG successfully reduces high rhGAA IgG antibody titers in a CRIM-negative infantile Pompe disease patient
  di: Rairikar, Mugdha, et al.
  Pubblicazione: (2017)